Author

d. C. Braden

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Alp· 1 shared A. C. Straub· 1 shared A. Casey· 1 shared A. Fagunloye· 1 shared A. V. LEE· 1 shared B. A. Freeman· 1 shared C. A. Carola· 1 shared C. Uvale· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Alp

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivAug 11, 2023

Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapies.

L. Hong, d. C. Braden, Y. Zhao…·C. A. Carola

This paper identifies nitroalkenes that inhibit RAD51-mediated homologous recombination, enhancing DNA damage in triple-negative breast cancer cells and showing potential as anticancer agents.

DOI 10.1016/j.redox.2023.102856

humanproteomics